Last reviewed · How we verify

NCT03397368

Evaluation of Transperineal US in Stress Incontinence

Status unknown Last updated 6 August 2019
What this trial tests

trial testing Transperineal Ultrasound - in Stress Incontinence, Female in 50 participants. Status unknown.

Timeline
16 January 2018
Primary endpoint
2 November 2019
8 December 2019

Quick facts

Lead sponsorAljazeera Hospital
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment50
Start date16 January 2018
Primary completion2 November 2019
Estimated completion8 December 2019
Sites2 locations across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Aljazeera Hospital

Who can join

Adults 20 to 75, female only, with Stress Incontinence, Female. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Stress urinary incontinence (SUI) has an observed prevalence of between 4%and 35%.Identified risk factors are aging, obesity and repeated pregnancies and deliveries. Urodynamic remains the gold standard for diagnosis in the past years. Trans labial ultrasound appears to have a good role in diagnosing stress incontinence

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Stress Incontinence, Female

Currently open trials in the same condition.

Other Aljazeera Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03397368.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing